Sign in
4/A

Changes in Ownership

Starling Oncology, Inc. Filed Acc 0001799191-22-000052

Chief Medical Officer sold 199 shares at $2.03 ($404)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Podnos Yale Chief Medical Officer 2022-11-15 Sale −199 $2.03 $404 43,083 D: show line 1 in the form
Open-market sales · 199 sh · avg $2.03 · $404
Loading xslF345X03/edgardoc.xml…